Ordinaria, Menelisa M.

HRN: 22-70-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2023
CEFTRIAXONE 1G (VIAL)
03/09/2023
03/16/2023
IV
2gm
OD
DM Foot
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: